Exavir : Implementation and evaluation of experimental pharmacology skills acquisition by pharmacy students
Copyright © 2024 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved..
With the evolution of European and French regulations on animal experimentation in higher education, taking greater account of animal welfare, the University of Angers has developed a virtual animal experimentation software named Exavir. Used for practical work (PW) in physiology, pharmacology and toxicology in the Health, Sciences, and engineering curricula, Exavir can be used to simulate various experiments for teaching purposes, in vivo or ex vivo. Thanks to an original approach integrating serious games with different scenarios, students gain autonomy and become directly involved in their learning. In addition, Exavir's collaborative and participative development approach fosters inter-university partnerships and the emergence of innovative teaching methods. A hybrid pilot study carried out on a sample of 22 students in the Pharmacy Department of the Faculty of Health showed that Exavir improved students' acquisition of teaching skills in both physiology and pharmacology, compared with practical work only based on animal organs. These encouraging results demonstrate for the first time the pedagogical advantages of Exavir and confirm the interest in developing such a platform. In this context, it appears that Exavir also opens up the possibility of adapting the practical work offered within universities, and thus responding to the changing ethical issues of the coming decades.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Annales pharmaceutiques francaises - (2024) vom: 03. Apr. |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Exavir : mise en place et évaluation de l’acquisition de compétences en pharmacologie expérimentale par des étudiants en pharmacie |
|---|
| Beteiligte Personen: |
Bourreau, Clara [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 15.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.pharma.2024.03.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370693361 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370693361 | ||
| 003 | DE-627 | ||
| 005 | 20240415233704.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240406s2024 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.pharma.2024.03.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM370693361 | ||
| 035 | |a (NLM)38579926 | ||
| 035 | |a (PII)S0003-4509(24)00043-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Bourreau, Clara |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Exavir |b Implementation and evaluation of experimental pharmacology skills acquisition by pharmacy students |
| 246 | 3 | 3 | |a Exavir : mise en place et évaluation de l’acquisition de compétences en pharmacologie expérimentale par des étudiants en pharmacie |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a With the evolution of European and French regulations on animal experimentation in higher education, taking greater account of animal welfare, the University of Angers has developed a virtual animal experimentation software named Exavir. Used for practical work (PW) in physiology, pharmacology and toxicology in the Health, Sciences, and engineering curricula, Exavir can be used to simulate various experiments for teaching purposes, in vivo or ex vivo. Thanks to an original approach integrating serious games with different scenarios, students gain autonomy and become directly involved in their learning. In addition, Exavir's collaborative and participative development approach fosters inter-university partnerships and the emergence of innovative teaching methods. A hybrid pilot study carried out on a sample of 22 students in the Pharmacy Department of the Faculty of Health showed that Exavir improved students' acquisition of teaching skills in both physiology and pharmacology, compared with practical work only based on animal organs. These encouraging results demonstrate for the first time the pedagogical advantages of Exavir and confirm the interest in developing such a platform. In this context, it appears that Exavir also opens up the possibility of adapting the practical work offered within universities, and thus responding to the changing ethical issues of the coming decades | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Acquisition de compétences | |
| 650 | 4 | |a Expérimentation animale virtuelle | |
| 650 | 4 | |a Innovation pédagogique | |
| 650 | 4 | |a Pedagogical innovation | |
| 650 | 4 | |a Pharmacologie | |
| 650 | 4 | |a Pharmacology | |
| 650 | 4 | |a Physiologie | |
| 650 | 4 | |a Physiology | |
| 650 | 4 | |a Practical work | |
| 650 | 4 | |a Skills acquisition | |
| 650 | 4 | |a Toxicologie | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Travaux pratiques | |
| 650 | 4 | |a Virtual animal experimentation | |
| 700 | 1 | |a Chevrier, Tristan |e verfasserin |4 aut | |
| 700 | 1 | |a Desserrey, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Lusson, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Bessaguet, Flavien |e verfasserin |4 aut | |
| 700 | 1 | |a Faure, Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Legeay, Samuel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales pharmaceutiques francaises |d 1945 |g (2024) vom: 03. Apr. |w (DE-627)NLM000046493 |x 0003-4509 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:03 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pharma.2024.03.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 03 |c 04 | ||